Geneos Wealth Management’s Invesco FTSE RAFI Developed Markets ex-US ETF PXF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$550K Buy
7,272
+37
+0.5% +$2.78K 0.01% 705
2026
Q1
$506K Buy
7,235
+316
+5% +$22.3K 0.01% 702
2025
Q4
$454K Buy
6,919
+261
+4% +$16.5K 0.01% 693
2025
Q3
$407K Buy
6,658
+344
+5% +$20.5K 0.01% 711
2025
Q2
$363K Sell
6,314
-1,114
-15% -$60.4K 0.01% 803
2025
Q1
$386K Buy
7,428
+3,559
+92% +$182K 0.01% 709
2024
Q4
$185K Sell
3,869
-3,720
-49% -$185K 0.01% 871
2024
Q3
$396K Sell
7,589
-414
-5% -$20.8K 0.02% 610
2024
Q2
$390K Sell
8,003
-123
-2% -$6.1K 0.02% 556
2024
Q1
$403K Sell
8,126
-754
-8% -$35.9K 0.02% 547
2023
Q4
$421K Sell
8,880
-747
-8% -$33.2K 0.02% 522
2023
Q3
$419K Buy
9,627
+229
+2% +$10.3K 0.02% 502
2023
Q2
$423K Buy
9,398
+740
+9% +$33.2K 0.02% 494
2023
Q1
$381K Buy
8,658
+4,509
+109% +$199K 0.02% 497
2022
Q4
$172K Buy
4,149
+1,455
+54% +$57.5K 0.01% 669
2022
Q3
$94K Buy
2,694
+1,329
+97% +$52.2K 0.01% 822
2022
Q2
$54K Buy
1,365
+533
+64% +$23.2K ﹤0.01% 1251
2022
Q1
$38K Sell
832
-780
-48% -$36.7K ﹤0.01% 1498
2021
Q4
$76K Sell
1,612
-204
-11% -$9.71K ﹤0.01% 1287
2021
Q3
$85K Buy
1,816
+191
+12% +$9.16K ﹤0.01% 1239
2021
Q2
$78K Buy
1,625
+1,125
+225% +$54.5K ﹤0.01% 1267
2021
Q1
$23K Hold
500
– – ﹤0.01% 2011
2020
Q4
$23K Hold
500
– – ﹤0.01% 1826
2020
Q3
$17K Hold
500
– – ﹤0.01% 1737
2020
Q2
$17K Hold
500
– – ﹤0.01% 1697
2020
Q1
$14K Hold
500
– – ﹤0.01% 1662
2019
Q4
$21K Hold
500
– – ﹤0.01% 1665
2019
Q3
$19K Buy
+500
New +$19.7K ﹤0.01% 1638
2019
Q2
– Sell
-80
Closed -$3K – 2517
2019
Q1
$3K Hold
80
– – ﹤0.01% 2173
2018
Q4
$3K Hold
80
– – ﹤0.01% 2127
2018
Q3
$3K Buy
+80
New +$3.45K ﹤0.01% 2200

Other funds holding PXF

Geneos Wealth Management's PXF Position: Q2 2026 in Review

Geneos Wealth Management increased its Invesco FTSE RAFI Developed Markets ex-US ETF (PXF) stake by 0.51% in Q2 2026, buying an estimated $2.78K and bringing the position to 7,272 shares worth $550K. The position accounts for 0.01% of the portfolio, ranked #705.

Geneos Wealth Management first reported a position in PXF in Q3 2018 and has held it in 31 quarters since. 252 funds tracked by Wall St. Rank hold PXF as of Q2 2026.

  • Geneos Wealth Management held 7,272 shares of Invesco FTSE RAFI Developed Markets ex-US ETF worth $550K as of Q2 2026.
  • Geneos Wealth Management bought 37 Invesco FTSE RAFI Developed Markets ex-US ETF shares in Q2 2026, an estimated $2.78K.
  • Invesco FTSE RAFI Developed Markets ex-US ETF made up 0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #705 holding.
  • Geneos Wealth Management first reported a position in Invesco FTSE RAFI Developed Markets ex-US ETF in Q3 2018 and has held it in 31 quarters since.
  • 252 funds tracked by Wall St. Rank held Invesco FTSE RAFI Developed Markets ex-US ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.